Patients with intermediate-risk acute pulmonary embolism are at risk of hemodynamic deterioration, and identification of risk factors for decompensation could guide the administration of thrombolytics. We aimed to assess whether SpO2/FIO2 on presentation is associated with early hemodynamic deterioration in this population.
METHODS:
A retrospective chart review of subjects admitted between 2006 and 2018 with intermediate-risk pulmonary embolism (hemodynamically stable with right ventricle to left ventricle ratio > 0.9 or tricuspid annular plane systolic excursion < 18 mm). Early hemodynamic deterioration was defined as requirements for vasopressors or rescue thrombolytics within 48 h. Results are presented as median (interquartile range).
RESULTS:
A total of 178 subjects were included. Early hemodynamic deterioration occurred in 13% of the subjects and was associated with a median (interquartile range) lower SpO2/FIO2 on presentation in univariate analysis (243 [123–275] versus 438 [335–457], P < .001) and in a multivariate analysis, including heart rate and right ventricle to left ventricle ratio as covariates (odds ratio 0.992, 95% CI 0.987–0.996; P < .001). The initial SpO2/FIO2 predicted hemodynamic deterioration with an area under the receiver operating characteristic curve of 0.81 and a threshold of 260 was associated with a sensitivity of 74% and specificity of 88%. Sensitivity analyses restricted to subjects with hypoxemia on presentation and subjects with an elevated troponin level led to similar results.
CONCLUSIONS:
In intermediate-risk pulmonary embolism, SpO2/FIO2 on presentation can help predict the risk of early hemodynamic deterioration.
KonstantinidesSV, TorbickiA, AgnelliG, DanchinN, FitzmauriceD, GalieN, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2014; 35(43):3033–3069, 3069a–3069k.
2.
GoldhaberSZ, VisaniL, De RosaM. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet, 1999; 353(9162):1386–1389.
3.
WanS, QuinlanDJ, AgnelliG, EikelboomJW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation, 2004; 110(6):744–749.
4.
AujeskyD, ObroskyDS, StoneRA, AubleTE, PerrierA, CornuzJ, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med, 2005; 172(8):1041–1046.
5.
ZhouXY, BenSQ, ChenHL, NiSS. The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis. Respir Res, 2012; 13:111.
6.
KasperW, KonstantinidesS, GeibelA, OlschewskiM, HeinrichF, GrosserKD, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol, 1997; 30(5):1165–1171.
7.
MeneveauN, MingLP, SérondeMF, MersinN, SchieleF, CaulfieldF, et al. In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. Eur Heart J, 2003; 24(15):1447–1454.
8.
BovaC, PesaventoR, MarchioriA, PallaA, EneaI, PengoV, et al.; TELESIO Study Group. Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up. J Thromb Haemost, 2009; 7(6):938–944.
9.
KabrhelC, OkechukwuI, HariharanP, TakayesuJK, MacMahonP, HaddadF, ChangY. Factors associated with clinical deterioration shortly after PE. Thorax, 2014; 69(9):835–842.
10.
GiannitsisE, Müller-BardorffM, KurowskiV, WeidtmannB, WiegandU, KampmannM, KatusHA. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation, 2000; 102(2):211–217.
11.
SantolicandroA, PredilettoR, FornaiE, FormichiB, BegliominiE, Giannella-NetoA, GiuntiniC. Mechanisms of hypoxemia and hypocapnia in pulmonary embolism. Am J Respir Crit Care Med, 1995; 152(1):336–347.
12.
D'AlonzoGE, BowerJS, DeHartP, DantzkerDR. The mechanisms of abnormal gas exchange in acute massive pulmonary embolism. Am Rev Respir Dis, 1983; 128(1):170–172.
13.
ManierG, CastaingY, GuenardH. Determinants of hypoxemia during the acute phase of pulmonary embolism in humans. Am Rev Respir Dis, 1985; 132(2):332–338.
14.
McIntyreKM, SasaharaAA. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol, 1971; 28(3):288–294.
15.
JardinF, GurdjianF, DesfondsP, FouilladieuJL, MargairazA. Hemodynamic factors influencing arterial hypoxemia in massive pulmonary embolism with circulatory failure. Circulation, 1979; 59(5):909–912.
16.
SubramanianM, RamaduraiS, ArthurP, GopalanS. Hypoxia as an independent predictor of adverse outcomes in pulmonary embolism. Asian Cardiovasc Thorac Ann, 2018; 26(1):38–43.
17.
BraudeS, Martens-NielsenJ. Severe refractory hypoxaemia in submassive pulmonary embolism: a surrogate marker of severe right ventricular dysfunction and indication for thrombolysis. Intern Med J, 2012; 42(6):712–715.
18.
GrifoniS, OlivottoI, CecchiniP, PieralliF, CamaitiA, SantoroG, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation, 2000; 101(24):2817–2822.
19.
CoudroyR, FratJP, BoissierF, ContouD, RobertR, ThilleAW. Early identification of acute respiratory distress syndrome in the absence of positive pressure ventilation: implications for revision of the Berlin Criteria for Acute Respiratory Distress Syndrome. Crit Care Med, 2018; 46(4):540–546.
20.
ChanquesG, RibouletF, MolinariN, CarrJ, JungB, PradesA, et al. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiol, 2013; 79(12):1344–1355.
21.
JiménezD, AujeskyD, MooresL, GomezV, LoboJL, UresandiF, et al.; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med, 2010; 170(15):1383–1389.
22.
KonstantinidesS, GeibelA, OlschewskiM, HeinrichF, GrosserK, RauberK, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation, 1997; 96(3):882–888.
InceO, AltintasN, FindikS, SariaydinM. Risk stratification in submassive pulmonary embolism via alveolar-arterial oxygen gradient. Hippokratia, 2014; 18(4):333–339.
25.
PisaniL, RoozemanJP, SimonisFD, GiangregorioA, van der HoevenSM, SchoutenLR, et al.; MARS consortium. Risk stratification using SpO2/FIO2 and PEEP at initial ARDS diagnosis and after 24 h in patients with moderate or severe ARDS. Ann Intensive Care, 2017; 7(1):108.
26.
BrownSM, DuggalA, HouPC, TidswellM, KhanA, ExlineM, et al.; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network. Nonlinear imputation of PaO2/FIO2 from SpO2/FIO2 among mechanically ventilated patients in the ICU: a prospective, observational study. Crit Care Med, 2017; 45(8):1317–1324.
27.
FesticE, BansalV, KorDJ, GajicO. US Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG–LIPS). SpO2/FIO2 ratio on hospital admission is an indicator of early acute respiratory distress syndrome development among patients at risk. J Intensive Care Med, 2015; 30(4):209–216.
28.
KwackWG, LeeDS, MinH, ChoiYY, YunM, KimY, et al. Evaluation of the SpO2/FIO2 ratio as a predictor of intensive care unit transfers in respiratory ward patients for whom the rapid response system has been activated. PloS One, 2018; 13(7):e0201632.
29.
KimWY, LeeJ, LeeJR, JungYK, KimHJ, HuhJW, et al. A risk scoring model based on vital signs and laboratory data predicting transfer to the intensive care unit of patients admitted to gastroenterology wards. J Crit Care, 2017; 40:213–217.
30.
RivielloED, KiviriW, TwagirumugabeT, MuellerA, Banner-GoodspeedVM, OfficerL, et al. Hospital incidence and outcomes of the acute respiratory distress syndrome using the Kigali modification of the Berlin Definition. Am J Respir Crit Care Med, 2016; 193(1):52–59.
31.
SimonM, WachsC, BrauneS, de HeerG, FringsD, KlugeS. High-flow nasal cannula versus bag-valve-mask for preoxygenation before intubation in subjects with hypoxemic respiratory failure. Respir Care, 2016; 61(9):1160–1167.
